The Artificial Pancreas Device System (APDS) industry is witnessing transformative advancements driven by increasing diabetes prevalence and technological innovation. Continuous improvements in closed-loop insulin delivery systems are catalyzing the industry size expansion, reflecting robust market growth and evolving market dynamics.Market Size and Overview Artificial pancreas device system...